Login
$HIND
$1.53 -$0.05 (3.16%) Close

$HIND 8-K/A SEC Filings

Filed On Filing
12 Sep 2025 8-K/A: Financial Statements and Exhibits

On July 8, 2024, ReShape, Vyome, and Merger Sub, entered into the Merger Agreement (“Merger”). Pursuant to the Merger Agreement, and subject to the satisfaction or waiver of the conditions specified therein, Merger Sub shall be merged wi...

22 Mar 2022 8-K/A: Results of Operations and Financial Condition

Full Year Revenue Increased by Approximately 20%, from $11.3 M to $13.6 M

30 May 2019 8-K/A: Departure/Election of Directors or Officers; Compensation

On May 22, 2019, Obalon Therapeutics, Inc. (the “Company”) filed a Form 8-K with the U.S. Securities and Exchange Commission (the “Original Report”) to report that Kelly Huang had notified the Board of Directors (the “Board”) of his resi...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support